期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

慢性乙型肝炎抗病毒治疗的研究进展 被引量：5

原文传递
导出
摘要 抗病毒治疗是慢性病毒性乙型肝炎治疗的核心问题之一。本文就慢性病毒性乙型肝炎抗病毒药物的研究进展、联合治疗的现状以及目前抗病毒治疗存在的问题和可能的对策作一综述。
作者 饶敏 张淑玲 董继华
机构地区 华中科技大学同济医学院附属协和医院传染科
出处 《国际病毒学杂志》 2006年第6期177-181,共5页 International Journal of Virology
关键词 慢性病毒性乙型肝炎 抗病毒治疗 联合治疗
分类号 R512.62 [医药卫生—内科学]
  • 相关文献

参考文献20

  • 1Moskovitz DN,Osiowy C,Giles E,et al.Response to long-term lamivudine treatment (up to 5 years) in patients with severe chronic hepatitis B,role of genotype and drug resistance.J Viral Hepat.2005,12(4):398-404.
  • 2Tseng PL,Lu SN,Tung HD,et al.Determinants of early mortality and benefits of lamivudine therapy in patients with hepatitis B virusrelated decompensated liver cirrhosis.J Viral Hepat.2005,12(4):386-92.
  • 3Di Marco V,Di Stefano R,Ferraro D,et al.HBV-DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.Antivir Ther.2005,10 (3):431-9.
  • 4Kowalik-Mikolajewska B,Aniszewska M.Lamivudine treatment of chronic hepatitis B in children after treatment with interferon alfa -evaluation of effectiveness of prolonged therapy.Med Wieku Rozwoj.2004,3(4):901-910.
  • 5Artan R.Lamivudine monotherapy in children with immune-tolerant chronic hepatitis B virus.J Chemother.2005,17(2):198-202.
  • 6Marcellin P,Chang T T,Lim SG,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.N Engl J Med.2003,348(9):808-812.
  • 7HAdefovir Dipivoxilziyannis SJ,Tassopoulos NC,Heathcote EJ,et al.Long-term therapy with Adefovir Dipivoxil for HBeAg-negative chronic hepatitis B.N Engl J Med.2005,352(26):2673-81.
  • 8Barcena MR,Cid GL,Lopez SP.Use of adefovir in the treatment of the chronic hepatitis B virus infection with resistance to lamivudine.Transplant Proc,2003,35 (5):1841-1845.
  • 9YaoGB ZhangDF WangBE等.恩替卡韦治疗慢HBV的剂量和疗效的研究[J].中华肝脏病杂志,2005,13(7):484-7.
  • 10Foster WK,Miller DS,Scougall CA,et al.Effect of antiviral treatment with entecavir on age-and dose-related outcomes of duck hepatitis B virus infection.J Virol.2005,79(9):5819-32.

二级参考文献14

  • 1杨春,肖永红,管小琴,袁哲.拉米夫定治疗慢性乙型肝炎的临床观察及病理学研究[J].中华肝脏病杂志,2004,12(6):364-367. 被引量：24
  • 2陈汉,吴孟超.原发性肝癌手术后复发再治疗方法的选择[J].中华医学杂志,1997,77(3):163-164. 被引量：12
  • 3Core working party for Asia-Pacific consensus on hepatitis B and C.Consensus statements on the prevention and management of hepatitis B and C in the Asia-Pacific region. J Gastroenterol Hepatol, 2000, 15:825-841.
  • 4Leung NW, Lia CL, Chang TT, et al. Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy. Hepatology, 2001,33:1527-1532.
  • 5Liaw YF, Leung NW, Chang TT, et al. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Gastroenterology,2000, 119:172-180.
  • 6Pramoolsinsup C. Management of viral hepatitis B. J Gastroenterol Hepatol,2002, 17 Suppl: S125-S145.
  • 7Moshier JA, Mutchnick MG, Dosescu J, et al. Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells. J Hepatol, 1996,25: 814-820.
  • 8Balch G, Izzo F, Chiao P, et al. Activation of human Kupffer cells by thymostimulin (TP-1) to produce cytotoxicity against human hepatocellular cancer. Ann Surg Oncol, 1997, 4: 149-155.
  • 9Chien RN, Liaw YF, Chen TC, et al. Efficacy of thymosin alpha 1 in patients with chronic hepatitis B: a randomized, controlled trial.Hepatology, 1998, 27: 1383-1387.
  • 10Cammá C, Giunta M, Andreone P, et al. Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based approach.J Hepatol, 2001, 34: 593-602.

共引文献17

同被引文献57

引证文献5

二级引证文献9

国际病毒学杂志
2006年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部